Holdings of T. Rowe Price Health Sciences Portfolio
T. ROWE PRICE EQUITY SERIES, INC. · Original filing · Compare with another fund · Report an error
- Net assets
- 662.6M $ including 625.9M $ in equities, 94.5 %
- Positions
- 168 in 13 countries
- Bond lines
- 1 from 1 company
- Top ten
- 39.7 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 73,591 | 67.7M $ | 10.22 % |
| 2 | Thermo Fisher Scientific Inc | 54,941 | 27M $ | 4.08 % |
| 3 | Intuitive Surgical Inc | 52,937 | 24.4M $ | 3.68 % |
| 4 | Stryker Corp | 70,352 | 23.1M $ | 3.49 % |
| 5 | Merck & Co Inc | 190,448 | 22.9M $ | 3.46 % |
| 6 | AstraZeneca PLC | 106,710 | 21M $ | 3.18 % |
| 7 | UnitedHealth Group Inc | 75,926 | 20.5M $ | 3.10 % |
| 8 | Argenx SE | 26,555 | 19.4M $ | 2.93 % |
| 9 | AbbVie Inc | 87,748 | 19.1M $ | 2.88 % |
| 10 | Regeneron Pharmaceuticals, Inc. | 23,001 | 17.8M $ | 2.68 % |
| 11 | Gilead Sciences Inc | 124,085 | 17.3M $ | 2.61 % |
| 12 | Johnson & Johnson | 66,600 | 16.3M $ | 2.46 % |
| 13 | Vertex Pharmaceuticals Inc | 36,045 | 16.1M $ | 2.43 % |
| 14 | Danaher Corp | 71,673 | 13.6M $ | 2.05 % |
| 15 | Alnylam Pharmaceuticals Inc | 32,630 | 10.8M $ | 1.63 % |
| 16 | Revolution Medicines Inc | 92,384 | 9M $ | 1.36 % |
| 17 | United Therapeutics Corp | 15,087 | 8.9M $ | 1.35 % |
| 18 | BeOne Medicines Ltd | 355,752 | 8M $ | 1.20 % |
| 19 | Roivant Sciences Ltd | 271,253 | 7.5M $ | 1.13 % |
| 20 | Protagonist Therapeutics Inc | 69,663 | 7.3M $ | 1.11 % |
| 21 | Insmed Inc | 43,093 | 7M $ | 1.06 % |
| 22 | Natera Inc | 35,183 | 7M $ | 1.06 % |
| 23 | Summit Therapeutics Inc | 362,900 | 6.9M $ | 1.04 % |
| 24 | Tenet Healthcare Corp | 36,032 | 6.8M $ | 1.03 % |
| 25 | BrightSpring Health Services Inc | 154,105 | 6.6M $ | 0.99 % |
| 26 | Amgen Inc | 18,569 | 6.5M $ | 0.99 % |
| 27 | Boston Scientific Corp | 97,805 | 6.1M $ | 0.93 % |
| 28 | HCA Healthcare Inc | 12,847 | 6.1M $ | 0.92 % |
| 29 | Guardant Health Inc | 65,638 | 6.1M $ | 0.92 % |
| 30 | CVS Health Corp | 79,198 | 5.7M $ | 0.86 % |
| 31 | Kymera Therapeutics Inc | 61,124 | 5.1M $ | 0.77 % |
| 32 | Cigna Group/The | 18,644 | 5M $ | 0.75 % |
| 33 | CG oncology Inc | 69,646 | 4.7M $ | 0.71 % |
| 34 | Cardinal Health, Inc. | 21,571 | 4.6M $ | 0.69 % |
| 35 | Elevance Health Inc | 15,076 | 4.4M $ | 0.67 % |
| 36 | Krystal Biotech Inc | 16,983 | 4.4M $ | 0.66 % |
| 37 | Ionis Pharmaceuticals Inc | 55,343 | 4.2M $ | 0.63 % |
| 38 | Scholar Rock Holding Corp | 83,968 | 4.1M $ | 0.62 % |
| 39 | Bridgebio Pharma Inc | 53,496 | 4M $ | 0.60 % |
| 40 | Chugai Pharmaceutical Co Ltd | 69,900 | 3.9M $ | 0.58 % |
| 41 | Structure Therapeutics Inc | 77,611 | 3.7M $ | 0.56 % |
| 42 | Praxis Precision Medicines Inc | 11,574 | 3.7M $ | 0.56 % |
| 43 | Celcuity Inc | 32,571 | 3.7M $ | 0.56 % |
| 44 | Royalty Pharma PLC | 77,100 | 3.7M $ | 0.56 % |
| 45 | Cencora Inc | 11,189 | 3.5M $ | 0.53 % |
| 46 | CENTESSA PHARMACEUTICALS PLC | 83,369 | 3.3M $ | 0.50 % |
| 47 | Vera Therapeutics Inc | 77,381 | 3.1M $ | 0.47 % |
| 48 | Nuvalent Inc | 28,970 | 3M $ | 0.45 % |
| 49 | Apogee Therapeutics Inc | 34,862 | 2.9M $ | 0.44 % |
| 50 | Abivax SA | 24,954 | 2.8M $ | 0.42 % |
| 51 | Edwards Lifesciences Corp | 34,286 | 2.7M $ | 0.41 % |
| 52 | Cytokinetics Inc | 40,699 | 2.7M $ | 0.40 % |
| 53 | Incyte Corp | 28,283 | 2.7M $ | 0.40 % |
| 54 | Spyre Therapeutics Inc | 52,747 | 2.7M $ | 0.40 % |
| 55 | Dianthus Therapeutics Inc | 29,534 | 2.5M $ | 0.37 % |
| 56 | Crinetics Pharmaceuticals Inc | 66,707 | 2.4M $ | 0.37 % |
| 57 | Tenax Therapeutics Inc | 151,450 | 2.4M $ | 0.37 % |
| 58 | Madrigal Pharmaceuticals Inc | 4,568 | 2.4M $ | 0.36 % |
| 59 | Immunome Inc | 107,386 | 2.3M $ | 0.35 % |
| 60 | IQVIA Holdings Inc | 13,072 | 2.2M $ | 0.34 % |
| 61 | Kodiak Sciences Inc | 56,241 | 2.1M $ | 0.32 % |
| 62 | Caris Life Sciences Inc | 116,415 | 2.1M $ | 0.31 % |
| 63 | Belite Bio Inc | 12,700 | 2M $ | 0.31 % |
| 64 | Monte Rosa Therapeutics Inc | 111,845 | 1.8M $ | 0.28 % |
| 65 | Terns Pharmaceuticals Inc | 33,976 | 1.8M $ | 0.27 % |
| 66 | Axsome Therapeutics Inc | 10,053 | 1.7M $ | 0.26 % |
| 67 | Alignment Healthcare Inc | 94,456 | 1.7M $ | 0.25 % |
| 68 | Moderna Inc | 32,300 | 1.6M $ | 0.25 % |
| 69 | Alumis Inc | 72,447 | 1.6M $ | 0.24 % |
| 70 | Beam Therapeutics Inc | 66,698 | 1.6M $ | 0.24 % |
| 71 | Revvity Inc | 17,506 | 1.5M $ | 0.23 % |
| 72 | West Pharmaceutical Services Inc | 6,000 | 1.5M $ | 0.23 % |
| 73 | Sonova Holding AG | 6,462 | 1.5M $ | 0.22 % |
| 74 | IDEXX Laboratories Inc | 2,621 | 1.5M $ | 0.22 % |
| 75 | Sionna Therapeutics Inc | 35,707 | 1.4M $ | 0.22 % |
| 76 | Oruka Therapeutics Inc | 28,926 | 1.4M $ | 0.21 % |
| 77 | ORIC Pharmaceuticals Inc | 110,459 | 1.4M $ | 0.21 % |
| 78 | McKesson Corp | 1,545 | 1.3M $ | 0.20 % |
| 79 | MBX Biosciences Inc | 44,028 | 1.3M $ | 0.20 % |
| 80 | Mirum Pharmaceuticals Inc | 14,079 | 1.3M $ | 0.20 % |
| 81 | Billiontoone Inc | 16,222 | 1.3M $ | 0.19 % |
| 82 | Rhythm Pharmaceuticals Inc | 14,695 | 1.3M $ | 0.19 % |
| 83 | Erasca Inc | 76,100 | 1.2M $ | 0.19 % |
| 84 | Arrowhead Pharmaceuticals Inc | 18,900 | 1.2M $ | 0.18 % |
| 85 | Immunocore Holdings PLC | 39,016 | 1.2M $ | 0.18 % |
| 86 | Palvella Therapeutics Inc | 9,427 | 1.2M $ | 0.18 % |
| 87 | Rapport Therapeutics Inc | 37,225 | 1.2M $ | 0.18 % |
| 88 | Nurix Therapeutics Inc | 73,686 | 1.1M $ | 0.17 % |
| 89 | Vaxcyte Inc | 19,250 | 1.1M $ | 0.17 % |
| 90 | Centene Corp | 31,861 | 1M $ | 0.16 % |
| 91 | Bio-Rad Laboratories Inc | 3,700 | 1M $ | 0.16 % |
| 92 | Novo Nordisk A/S | 27,816 | 1M $ | 0.15 % |
| 93 | MoonLake Immunotherapeutics | 54,070 | 1M $ | 0.15 % |
| 94 | Kestra Medical Technologies Ltd | 48,776 | 972.1K $ | 0.15 % |
| 95 | WaVe Life Sciences Ltd | 128,523 | 931.8K $ | 0.14 % |
| 96 | Encompass Health Corp | 9,603 | 928.9K $ | 0.14 % |
| 97 | Stoke Therapeutics Inc | 28,000 | 911.7K $ | 0.14 % |
| 98 | BEONE MEDICINES LTD | 2,980 | 885K $ | 0.13 % |
| 99 | Charles River Laboratories International Inc | 4,900 | 845.3K $ | 0.13 % |
| 100 | Celldex Therapeutics Inc | 26,430 | 838.4K $ | 0.13 % |
The bonds it holds
1 company, one bond line. Only issuers whose shares this site already serves appear here.
| Rank | Company | Bond lines | Value | Weight |
|---|---|---|---|---|
| 1 | Immunocore Holdings PLC | 1 | 666.2K $ | 0.10 % |
Sector breakdown
- Health care 68.4 %
- Unattributed 31.6 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 97.8 %
- HKD 1.3 %
- JPY 0.6 %
- CHF 0.2 %
- EUR 0.1 %
The quoted currency of each line, as declared.
Country breakdown
- United States 88.4 %
- United Kingdom 3.4 %
- Netherlands 3.3 %
- Bermuda 1.4 %
- Hong Kong SAR China 1.3 %
- Japan 0.6 %
- Cayman Islands 0.5 %
- France 0.5 %
- Switzerland 0.2 %
- Denmark 0.2 %
- Singapore 0.1 %
- British Virgin Islands 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 148 | 553.1M $ | 88.37 % |
| 2 | United Kingdom | 2 | 21.3M $ | 3.41 % |
| 3 | Netherlands | 3 | 20.4M $ | 3.25 % |
| 4 | Bermuda | 2 | 8.5M $ | 1.36 % |
| 5 | Hong Kong SAR China | 1 | 8M $ | 1.28 % |
| 6 | Japan | 1 | 3.9M $ | 0.62 % |
| 7 | Cayman Islands | 4 | 3.4M $ | 0.54 % |
| 8 | France | 2 | 3.3M $ | 0.52 % |
| 9 | Switzerland | 1 | 1.5M $ | 0.24 % |
| 10 | Denmark | 1 | 1M $ | 0.16 % |
| 11 | Singapore | 1 | 931.8K $ | 0.15 % |
| 12 | British Virgin Islands | 1 | 660.7K $ | 0.11 % |
Cite this page
Titelia. "Holdings of T. Rowe Price Health Sciences Portfolio". https://titelia.com/en/funds/S000002083